Patent Assignment
Reel/Frame 058682/0058
Change of Name
Recorded: 2022-01-10
Pages: 4
Assignor
KALIVIR IMMUNOTHERAPEUTICS LLC
Executed: 2021-04-01
Assignee
KALIVIR IMMUNOTHERAPEUTICS, INC.
240 ALPHA DRIVE, PITTSBURGH, PENNSYLVANIA, 15238
Covered Property
(1)
Modified Extracellular Enveloped Virus
Application:
17/494,322 →
Publication:
US 2022/0049228
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.